BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 19426420)

  • 1. Complications of continuous renal replacement therapy.
    Finkel KW; Podoll AS
    Semin Dial; 2009; 22(2):155-9. PubMed ID: 19426420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous renal replacement therapy: cause and treatment of electrolyte complications.
    Fall P; Szerlip HM
    Semin Dial; 2010; 23(6):581-5. PubMed ID: 21166876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Handling continuous renal replacement therapy-related adverse effects in intensive care unit patients: the dialytrauma concept.
    Maynar Moliner J; Honore PM; Sánchez-Izquierdo Riera JA; Herrera Gutiérrez M; Spapen HD
    Blood Purif; 2012; 34(2):177-85. PubMed ID: 23095418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Continuous renal replacement therapies (CRRT) will remain the most widely adopted dialysis modality in the critically ill].
    Morabito S; Pistolesi V; Cibelli L; Pierucci A
    G Ital Nefrol; 2009; 26(1):13-21. PubMed ID: 19255959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amino Acid requirements in critically ill patients with acute kidney injury treated with continuous renal replacement therapy.
    Btaiche IF; Mohammad RA; Alaniz C; Mueller BA
    Pharmacotherapy; 2008 May; 28(5):600-13. PubMed ID: 18447659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrolyte disorders and substitution fluid in continuous renal replacement therapy.
    Locatelli F; Pontoriero G; Di Filippo S
    Kidney Int Suppl; 1998 May; 66():S151-5. PubMed ID: 9573593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection of dialysate and replacement fluids and management of electrolyte and Acid-base disturbances.
    Kraus MA
    Semin Dial; 2009; 22(2):137-40. PubMed ID: 19426416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of RIFLE classification on prognosis of critically ill patients with acute kidney injury treated with continuous renal replacement therapy.
    Li WX; Chen HD; Wang XW; Zhao S; Chen XK; Zheng Y; Song Y
    Chin Med J (Engl); 2009 May; 122(9):1020-5. PubMed ID: 19493435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acid-base balance and replacement solutions in continuous renal replacement therapies.
    Feriani M; Dell'Aquila R
    Kidney Int Suppl; 1998 May; 66():S156-9. PubMed ID: 9573594
    [No Abstract]   [Full Text] [Related]  

  • 10. Modalities of continuous renal replacement therapy: technical and clinical considerations.
    Cerdá J; Ronco C
    Semin Dial; 2009; 22(2):114-22. PubMed ID: 19426413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Continuous renal replacement therapy].
    Knotek M; Prkacin I; Skegro D; Sabljar-Matovinović M
    Lijec Vjesn; 2001; 123(9-10):255-8. PubMed ID: 11845582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional citrate anticoagulation for PrismaFlex continuous renal replacement therapy.
    Burry LD; Tung DD; Hallett D; Bailie T; Carvalhana V; Lee D; Ramganesh S; Richardson R; Mehta S; Lapinsky SE
    Ann Pharmacother; 2009 Sep; 43(9):1419-25. PubMed ID: 19690224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intermittent versus continuous renal replacement therapy: a matter of controversy.
    Davies HT; Leslie GD
    Intensive Crit Care Nurs; 2008 Oct; 24(5):269-85. PubMed ID: 18394900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic evaluation of continuous renal replacement therapy in acute renal failure.
    Klarenbach S; Manns B; Pannu N; Clement FM; Wiebe N; Tonelli M;
    Int J Technol Assess Health Care; 2009 Jul; 25(3):331-8. PubMed ID: 19619352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous renal replacement therapy in the treatment of acute renal failure: critical assessment is required.
    Himmelfarb J
    Clin J Am Soc Nephrol; 2007 Mar; 2(2):385-9. PubMed ID: 17699438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug dosing during continuous renal replacement therapy.
    Churchwell MD; Mueller BA
    Semin Dial; 2009; 22(2):185-8. PubMed ID: 19426426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors in critically ill surgical patients requiring continuous renal replacement therapy.
    Fertmann J; Wolf H; Kuchenhoff H; Hofner B; Jauch KW; Hartl WH
    J Nephrol; 2008; 21(6):909-18. PubMed ID: 19034876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alkalemia during continuous renal replacement therapy and mortality in critically ill patients.
    Demirjian S; Teo BW; Paganini EP
    Crit Care Med; 2008 May; 36(5):1513-7. PubMed ID: 18434895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Volume management in continuous renal replacement therapy.
    Bouchard J; Mehta RL
    Semin Dial; 2009; 22(2):146-50. PubMed ID: 19426418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview of pediatric renal replacement therapy in acute kidney injury.
    Goldstein SL
    Semin Dial; 2009; 22(2):180-4. PubMed ID: 19426425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.